Log In
Print this Print this

Spedra, Stendra, Zepeed, avanafil

Also known as: TA-1790

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionFast-acting phosphodiesterase-5 (PDE-5) inhibitor
Molecular Target Phosphodiesterase-5 (PDE-5)
Mechanism of ActionPhosphodiesterase-5 (PDE-5) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationErectile dysfunction (ED)
Indication DetailsTreat erectile dysfunction (ED); Treat erectile dysfunction (ED) in patients with Type I and Type II diabetes
Regulatory Designation U.S. - Special Protocol Assessment (Treat erectile dysfunction (ED))
PartnerEndo International plc;
JW Pharmaceutical Corp.;
Menarini Group;
Mist Pharmaceuticals LLC;
Vivus Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today